newsfilter
← Latest News
GlobeNewswire·

Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public Offering

BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 1